Viking Global Investors LP reduced its position in Molina Healthcare, Inc. (NYSE:MOH) by 14.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,672,822 shares of the company’s stock after selling 274,385 shares during the period. Viking Global Investors LP owned 2.80% of Molina Healthcare worth $128,272,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Renaissance Technologies LLC raised its position in Molina Healthcare by 53.5% during the 4th quarter. Renaissance Technologies LLC now owns 2,156,150 shares of the company’s stock worth $165,334,000 after buying an additional 751,800 shares during the last quarter. Jana Partners LLC grew its stake in shares of Molina Healthcare by 52.5% during the 3rd quarter. Jana Partners LLC now owns 2,125,351 shares of the company’s stock worth $146,139,000 after purchasing an additional 731,992 shares during the period. Iridian Asset Management LLC CT acquired a new stake in shares of Molina Healthcare during the 4th quarter worth approximately $128,179,000. Victory Capital Management Inc. grew its stake in Molina Healthcare by 36.0% in the 4th quarter. Victory Capital Management Inc. now owns 1,590,409 shares of the company’s stock valued at $121,953,000 after acquiring an additional 420,756 shares during the period. Finally, Tiedemann Wealth Management LLC grew its stake in Molina Healthcare by 7.8% in the 3rd quarter. Tiedemann Wealth Management LLC now owns 1,440,066 shares of the company’s stock valued at $135,000 after acquiring an additional 103,775 shares during the period. Institutional investors and hedge funds own 96.22% of the company’s stock.
A number of equities research analysts recently issued reports on MOH shares. Zacks Investment Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price target on the stock in a research note on Tuesday, January 2nd. Goldman Sachs assumed coverage on Molina Healthcare in a report on Wednesday, January 3rd. They set a “neutral” rating and a $83.00 price target on the stock. JPMorgan Chase & Co. upgraded shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a report on Tuesday, January 16th. ValuEngine upgraded shares of Molina Healthcare from a “hold” rating to a “buy” rating in a report on Friday, March 2nd. Finally, Raymond James Financial reiterated a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $75.57.
Molina Healthcare, Inc. (NYSE:MOH) traded up $0.96 during trading on Friday, reaching $76.83. The company’s stock had a trading volume of 1,619,136 shares, compared to its average volume of 988,783. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.35 and a quick ratio of 1.35. The firm has a market capitalization of $4,588.83, a price-to-earnings ratio of -8.52, a price-to-earnings-growth ratio of 1.36 and a beta of 1.28. Molina Healthcare, Inc. has a 12 month low of $42.56 and a 12 month high of $93.98.
Molina Healthcare (NYSE:MOH) last posted its quarterly earnings data on Monday, February 12th. The company reported $0.34 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.11. Molina Healthcare had a positive return on equity of 17.64% and a negative net margin of 2.58%. The business had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.96 billion. equities research analysts anticipate that Molina Healthcare, Inc. will post 3.68 earnings per share for the current fiscal year.
In related news, Director Charles Z. Fedak sold 4,487 shares of the firm’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $72.55, for a total transaction of $325,531.85. Following the sale, the director now directly owns 20,648 shares in the company, valued at approximately $1,498,012.40. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Steven J. Orlando sold 1,500 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $72.77, for a total value of $109,155.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 379,775 shares of company stock worth $31,661,006. 6.20% of the stock is owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: “Viking Global Investors LP Reduces Stake in Molina Healthcare, Inc. (NYSE:MOH)” was originally posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/03/18/molina-healthcare-inc-moh-shares-sold-by-viking-global-investors-lp.html.
Molina Healthcare Profile
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.